Analysed ROGERS CORP (ROG:NYSE) News Sources
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
25-10-2026
yahoo.com
Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories
27-10-2026
yahoo.com
What is the current price of ROGERS CORP (ROG:NYSE)?
The current price of ROGERS CORP (ROG:NYSE) is $134.12.
ROGERS CORP (ROG:NYSE) absolute price change since previous trading day?
The absolute price change of ROGERS CORP (ROG:NYSE) since the previous trading day is $6.4.
ROGERS CORP (ROG:NYSE) percentage price change since previous trading day?
The percentage price change of ROGERS CORP (ROG:NYSE) since the previous trading day is 5.011%.
What is the most recent average sentiment score for ROGERS CORP (ROG:NYSE)?
The most recent average sentiment score for ROGERS CORP (ROG:NYSE) is 75 out of 100.
What is the most recent average sentiment for ROGERS CORP (ROG:NYSE)?
The most recent sentiment for ROGERS CORP (ROG:NYSE) is .
SEC-8K** Filing Available For ROGERS CORP (ROG:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.